Introduction
============

Fluid infusion is an essential part of proper medical and surgical management. The target hemodynamic parameters for goal-directed fluid therapy remain controversial, with concerns regarding the risk of overhydration. We used a splanchnic ischemia--reperfusion (I/R) model with a high mortality rate to test whether fluid infusion aimed to target constant left ventricular end-diastolic volume (LVEDV) would ameliorate physiologic and biologic parameters in this situation.

Methods
=======

Two groups of adult rats were subjected to 90 minutes of mesenteric ischemia followed by 150 minutes of reperfusion, with one group (I/R+Vol) receiving fluids (one-half glucose 5% and one-half Isohes^®^) to maintain the LVEDV at baseline levels during reperfusion, and the other group (I/R) receiving no extra fluids. A sham group (instrumented without I/R) served as controls.

Results
=======

In spite of a persisting acidosis, the LVEDV-directed fluid therapy was able to prevent the rapid fatal outcome, without evidence of overhydration (Figure [1](#F1){ref-type="fig"}), as demonstrated by the absence of an increased lung wet/dry weight ratio.
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Conclusion
==========

Early LVEDV-directed fluid therapy markedly improves the outcome from mesenteric I/R injury.
